Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine?: GISSI experience, 1984-1993

The use of beta-blockers after acute myocardial infarction in Italy has increased more than three-fold in the last decade, but they are still prescribed to too few patients, especially those at higher risk, for whom the expected benefit is greater.